Forestay was founded in 2018 as the enterprise software fund of B-FLEXION, the private entrepreneurial investment firm established by the Bertarelli family, known for building Serono into the third-largest biotech business globally before its merger with Merck KGaA.
B-FLEXION partners with sophisticated capital to deliver exceptional value over the generations. As well as its investment funds seeding and building businesses in technology, private equity, real estate and hedge funds, B-FLEXION also focuses on growing operating businesses in transformative industries. Building on its heritage and of that of its founder and Chairman, these have been principally in life sciences, healthcare and digital health.